Dr. Reddy's Laboratories has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended-Release Tablets in two strengths-Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg in the United States market, as approved by the US Food and Drug Administration (USFDA).

Surya Roshni, a Delhi-based lighting and GI steel pipe manufacturer, announced that it has won order worth Rs. 58.39 crore, on Tuesday.

The stock of Reliance Industries formed bullish engulfing candle near upward sloping trendline support, which suggests bulls are taking control near the short-term support zone.

The stock of Zee Media was trailing by more than 3 per cent on Tuesday following an announcement that the company's Managing Director resigned and a downgrade of its credit ratings. 

The stocks to watch out for July 10 include Zee Media, Talwalkars, Fortis Healthcare, Dr. Reddy’s and Surya Roshni.

Generally, if the promoter stake of a stock has increased, it provides a sign of confidence of the promoters in the business. On the other hand, if promoter stake has decreased, it is not at all a healthful sign.

The construction company has received completion certificate and is entitled to a bonus of Rs. 37,90,08,000 towards earlier completion of the project.

Debt funds have witnessed huge outflow in the month of June 2019, while equity funds have maintained their inflows. Read on to find other details.

Pharma major Lupin informed the bourses that it has launched Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Following stocks are close to their 52-weeks low as at 2:08 p.m. on July 09, 2019.